17 May 2024
17 May 2024
Amidst congressional action and changes in payer pricing models, experts discuss what must be done for patients to reap benefits.
Highly potent active pharmaceutical ingredients (HPAPIs) are essential for chemotherapies and combination therapies. With specialised production facilities in great demand, what are the key challenges in HPAPI manufacturing?
The FDA granted BTD based on the initial data from the Phase I segment of the Phase I/II ALKOVE-1 trial in NSCLC patients.
The ALS space took another hit after experimental drug BIIB105 failed to show evidence of benefit in patients in the Phase I/II ALSpire trial.
IgGenix is planning to initiate a clinical trial later this year investigating its peanut allergy monoclonal antibody IGXN001.
Roche’s GLP-1/GIP receptor agonist, which was gained in the Carmot acquisition, showed an 18.8% weight loss in a Phase Ib trial.
The deal will facilitate in the GMP-compliant manufacturing of Galapagos’ CAR-T haemato-oncology clinical programme.
Deudomperidone is being analysed in Phase II trial in adults with diabetic gastroparesis.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
